Andrés Finzi

Andrés Finzi

Université de Montréal

H-index: 58

North America-Canada

About Andrés Finzi

Andrés Finzi, With an exceptional h-index of 58 and a recent h-index of 47 (since 2020), a distinguished researcher at Université de Montréal, specializes in the field of HIV-1, Env, ADCC, CD4, accessory proteins.

His recent articles reflect a diverse array of research interests and contributions to the field:

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission (preprint)

Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4+ T-Cells by Decreasing Viral Release

Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial

Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens

Plasma human immunodeficiency virus 1 soluble glycoprotein 120 association with correlates of immune dysfunction and inflammation in antiretroviral therapy–treated individuals …

Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis

Deciphering Fc-effector functions against SARS-CoV-2

Andrés Finzi Information

University

Position

/ CRCHUM

Citations(all)

11963

Citations(since 2020)

8150

Cited By

6109

hIndex(all)

58

hIndex(since 2020)

47

i10Index(all)

158

i10Index(since 2020)

145

Email

University Profile Page

Google Scholar

Andrés Finzi Skills & Research Interests

HIV-1

Env

ADCC

CD4

accessory proteins

Top articles of Andrés Finzi

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission (preprint)

2024

Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4+ T-Cells by Decreasing Viral Release

bioRxiv

2024

Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial

The Lancet Infectious Diseases

2024/1/1

Andrés Finzi
Andrés Finzi

H-Index: 37

Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial

Transfusion

2024/3/21

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens

Iscience

2024/3/15

Plasma human immunodeficiency virus 1 soluble glycoprotein 120 association with correlates of immune dysfunction and inflammation in antiretroviral therapy–treated individuals …

The Journal of Infectious Diseases

2024/3/15

Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis

Viruses

2024/2/23

Nicolas Chomont
Nicolas Chomont

H-Index: 47

Andrés Finzi
Andrés Finzi

H-Index: 37

Deciphering Fc-effector functions against SARS-CoV-2

2024/2/15

Andrés Finzi
Andrés Finzi

H-Index: 37

Enhanced detection of antigen-specific T cells by a multiplexed AIM assay

Cell Reports Methods

2024/1/22

Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity

Proceedings of the National Academy of Sciences

2023/3/28

RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION

2023/1

Anthracyclines inhibit SARS-CoV-2 infection (preprint)

2023

Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations

Current Issues in Molecular Biology

2023/12/19

Jean-Pierre Routy
Jean-Pierre Routy

H-Index: 48

Andrés Finzi
Andrés Finzi

H-Index: 37

Development and validation of a highly specific in-house chemiluminescent-based serological assay for the detection of antibodies directed against the human monkeypox virus

Journal of virological methods

2023/12

Jérémie Prévost
Jérémie Prévost

H-Index: 19

Andrés Finzi
Andrés Finzi

H-Index: 37

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

Cell Reports Medicine

2023/3/21

Publisher Correction: Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission

Nature Microbiology

2023

Plasmatic HIV-1 soluble gp120 is associated with correlates of immune dysfunction and inflammation in ART-treated individuals with undetectable viremia.

The Journal of Infectious Diseases

2023/11/30

Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine

Cell Reports

2023/1/31

See List of Professors in Andrés Finzi University(Université de Montréal)